The FDA approved Biogen’s Alzheimer’s drug last year even as a panel of outside medical experts expressed concerns about its efficacy. Read More
Congress blasts FDA’s Aduhelm approval as ‘rife with irregularities’
The FDA approved Biogen’s Alzheimer’s drug last year even as a panel of outside medical experts expressed concerns about its efficacy. Read More
